27
1
1
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1076 |
Dexamethasone
MK 125,Prednisolone F,NSC 34521,Hexadecadrol,地塞米松 |
Glucocorticoid Receptor; Mitophagy; IL Receptor; SARS-CoV; Antibacterial; Antibiotic; Autophagy; Complement System; ADC Cytotoxin | Antibody-drug Conjugate/ADC Related; Autophagy; Endocrinology/Hormones; Immunology/Inflammation; Microbiology/Virology |
Dexamethasone (Hexadecadrol) 是一种糖皮质激素受体激动剂和一种 IL 受体调节剂。Dexamethasone 具有抗炎和免疫抑制活性,可诱导自噬。Dexamethasone 抑制 LPS 诱导的巨噬细胞炎症反应。 | |||
T0947 |
Dexamethasone acetate
Dexamethasone 21-acetate,醋酸地塞米松,Dexamethason acetate,NSC 39471 |
Glucocorticoid Receptor; Mitophagy; IL Receptor; Annexin A; NOS; Antibacterial; Autophagy; ADC Cytotoxin | Antibody-drug Conjugate/ADC Related; Autophagy; Endocrinology/Hormones; GPCR/G Protein; Immunology/Inflammation; Microbiology/Virology |
Dexamethasone acetate (NSC 39471) 是一种糖皮质素类甾体,有抗炎和免疫抑制活性。它可研究眼部感染。 | |||
T19277 |
Dexamethasone 9,11-epoxide
|
Others | Others |
Dexamethasone 9,11-epoxide 是一种萃取得到的化合物,是制备地塞米松的中间体。 | |||
T15102 |
Dexamethasone palmitate
地塞米松棕榈酸酯,DXP |
Glucocorticoid Receptor | Endocrinology/Hormones |
Dexamethasone palmitate (DXP) (DXP) 是 Dexamethasone 的前药。Dexamethasone 是糖皮质激素受体激动剂。与Dexamethasone 相比, DXP 对糖皮质激素受体的亲和力低 47 倍。DXP 显示出抗炎活性。 | |||
T6465 |
Dexamethasone Sodium Phosphate
Dexadreson,地塞米松磷酸钠,Dexagro,Dalalone |
IL Receptor; COX | Immunology/Inflammation; Neuroscience |
Dexamethasone Sodium Phosphate (Dexadreson) 是一种白细胞介素受体调节剂,具有抗炎和免疫抑制作用。它属于类固醇合成药物的强效糖皮质激素类。 | |||
T0947L |
Dexamethasone Phosphate disodium
地塞米松磷酸二钠,EGP-437,EGP437. Dex-Phos,EGP 437 |
Glucocorticoid Receptor | Endocrinology/Hormones |
Dexamethasone Phosphate disodium (EGP437. Dex-Phos) 是糖皮质激素受体激动剂。 | |||
T21074 |
Dexamethasone acetate
Dexamethasone 21-acetate monohydrate,Decadron-LA,Decadron |
Others | Others |
Dexamethasone acetate is an adrenocortical steroid. It is used in the treatment of many conditions, including rheumatic problems, a number of skin diseases, asthma, severe allergies, chronic obstructive lung disease, brain swelling, croup, and antibiotics | |||
T37361 |
6β-hydroxy Dexamethasone
|
Others | Others |
6β-hydroxy Dexamethasone is a metabolite of dexamethasone that is more hydrophilic than the parent compound. Dexamethasone is metabolized by CYP3A4; therefore, quantification of the dexamethasone metabolites, 6α- and 6β-hydroxy dexamethasone, can be used to determine CYP3A4 enzyme activity in humans., The formation of 6-hydroxy dexamethasone metabolites is species-specific, with hamsters producing the highest amount. In rats, dexamethasone hydroxylation is sex-specific, with male rats producing ... | |||
T39088 |
Mc-Dexamethasone
|
Others; Drug-Linker Conjugates for ADC | Antibody-drug Conjugate/ADC Related; Others |
Mc-Dexamethasone is a drug-linker conjugate for ADC . Mc-Dexamethasone is made toxin Dexamethasone conjugated to the non-cleavable MC linker. Dexamethasone is a glucocorticoid receptor agonist. | |||
T27152 |
Dexamethasone Beloxil
|
Others | Others |
Dexamethasone Beloxil is a glucocorticoid, Anti-inflammatory Agent. | |||
T27153 |
Dexamethasone cipecilate
NS126,NS-126,NS 126 |
Others | Others |
Dexamethasone cipecilate is a long-acting intranasal corticosteroid and a highly lipophilic anti-inflammatory corticosteroid. | |||
T69323 |
Dexamethasone sodium succinate
|
Others | Others |
Dexamethasone sodium succinate is the acetate salt form of dexamethasone, which is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. At high doses (e.g. 40 mg), it reduces the immune response. Dexamethasone acetate (NEOFORDEX®) is indicated in adults for the treatment of symptomatic multiple myeloma in combination with other medicinal products. Dexamethasone has been shown to induce multiple myeloma cell death (apoptosis) via a down-regul... | |||
T23984 |
Dexamethasone phosphate
Neodecadron,EGP437,Hexadrol phosphate,EGP 437,EGP-437 |
Others | Others |
Dexamethasone phosphate is a synthetic adrenal corticosteroid. It also has potent anti-inflammatory properties. | |||
T61525 |
Dexamethasone oxetanone
|
Others | Others |
Dexamethasone oxetanone (Dex-Ox) is a glucocorticoid-selective derivative of Dexamethasone (Dex) compound. It acts as an antiglucocorticoid and an antiprogestin, demonstrating notable agonist activity with both PR A and B isoforms [1] [2]. | |||
T31395 |
Dexamethason 21-tert-butylacetate
Decadron TBA,Dexamethasone tert-butylacetate |
Others | Others |
Dexamethason 21-tert-butylacetate is a biochemical. | |||
T2334 |
Avanafil
阿伐那非,TA1790 |
PDE | Metabolism |
Avanafil (TA1790) 是一种高活性PDE-5抑制剂,IC50=5.2 nM,对PDE1,PDE6和PDE11活性较低。 | |||
T22818 |
GSK9027
GR agonist 23a,GSK 9027,GSK-9027 |
Glucocorticoid Receptor | Endocrinology/Hormones |
GSK9027 (GR agonist 23a) 是一种非甾体糖皮质激素受体 (GR) 激动剂。GSK9027 (GR agonist 23a) 在2×GRE报告基因上对比地塞米松的活性属于部分激动剂,活性较地塞米松活性较弱。 | |||
T35386 |
Elotuzumab
Elotuzumab (anti-SLAMF7),BMS 901608,PDL 063,HuLuc 63 |
Others | Others |
Elotuzumab(HuLuc 63) (anti-SLAMF7) 是一种靶向 SLAMF7 受体的单克隆抗体。Elotuzumab (anti-SLAMF7) 是一种直接激活NK细胞并诱导抗体依赖性细胞毒性的化合物,可联合来那度胺和地塞米松 (Ld) 用于治疗多发性骨髓瘤。 | |||
T38034 |
MAO-IN-M30 dihydrochloride
M 30 dihydrochloride |
Monoamine Oxidase | Neuroscience |
MAO-IN-M30 dihydrochloride (M 30 dihydrochloride) 是一种口服活性,可通过血脑屏障的,脑选择性不可逆 MAO-A (IC50=37 nM) 和 MAO-B (IC50=57 nM) 抑制剂。MAO-IN-M30 dihydrochloride 是有效的铁螯合剂、自由基清除剂。MAO-IN-M30 dihydrochloride 对 Dexamethasone 诱导的脑细胞凋亡具有神经保护作用。MAO-IN-M30 dihydrochloride 在 MPTP 和 lactacystin 帕金森病模型中也显示出神经恢复活性。 | |||
T24189 |
J9
J-9,J 9 |
Others | Others |
J9 is an inhibitor of Glucocorticoid resistance. J9 reverses Dexamethasone Resistance in T-cell Acute Lymphoblastic Leukemia. | |||
T27999 |
MDK-4624
AMPKα1 activator C13,C13, Compound 13 |
Others | Others |
MDK-4624 is a AMPKα1 activator. MDK-4624 inhibits Helicobacter pylori-induced oxidative stresses and gastric epithelial cell apoptosis. MDK-4624 attenuates dexamethasone-induced osteoblast cell death. MDK-4624 potently inhibits melanoma cell proliferation | |||
T84472 |
1-Aminodecylidene bis-Phosphonic Acid
1-Amindecane-1,1-Diphosphonic Acid |
Others | Others |
1-Aminodecylidenebis-phosphonic acid, with its potent inhibitory effect on acid sphingomyelinase (IC50= 20 nM), shows selectivity by being less effective against neutral sphingomyelinase (IC50= >100 μM). Additionally, it entirely prevents dexamethasone-induced apoptosis in HepG2 cells. | |||
T85304 |
LX7101 hydrochloride
|
Others | Others |
LX7101 is a potent inhibitor of both LIM kinase (LIMK) 1 and 2, and Rho-associated kinase 1 (ROCK1) and ROCK2, with IC50 values of 32, 4.3, 69, and 32 nM, respectively. It is selective, demonstrated by its lack of cross-reactivity in a panel of binding assays involving 78 receptors, transporters, and an additional 430 kinases, at a concentration of 10 μM. The topical administration of LX7101 (3 μl of a 1 mg/ml solution) to the eye has been shown to reduce intraocular pressure in a dexamethasone-... | |||
T70904 |
Tylogenin
|
Others | Others |
Tylogenin, a steroidal aglycone generated by acid hydrolysis from two seasonal glycosides occurring in Tylophora sylvatica, inhibits IgE-induced basophil mediator release for allergic reactions. In the rabbit basophil-dependent serotonin release (BDSR) assay system, the inhibitory activity of tylogenin was significantly greater than that of its parent glycosides, tylophoroside and acetyltylophoroside, and that of dexamethasone. The activity of tylogenin was found to increase with the incubation ... | |||
T27790 |
Labradimil
RMP-7,ALK-01-040,Receptor-mediated permeabiliser-7,DRG0182,DRG 0182,DRG-0182 |
||
Labradimil is a bradykinin B2 receptor agonist. Labradimil increases the permeability of human brain microvascular endothelial cell monolayers. Labradimil enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tu | |||
T70346 |
TOP1362
|
Others | Others |
TOP1362 is a Narrow Spectrum Kinase Inhibitors Demonstrate Promise for the Treatment of Dry Eye Disease and Other Ocular Inflammatory Disorders. TOP1362 strongly inhibited the kinase targets p38α, Syk, Src, and Lck, blocked the rise in p38α expression in hyperosmolar Chang cells, and potently reduced inflammatory cytokine release in cellular models of innate and adaptive immunities. In the EIU model, TOP1362 dose-dependently attenuated the LPS-induced rise in inflammatory cell infiltration and o... | |||
T68306 |
INCB16562
|
Others | Others |
INCB16562 is a novel, selective, and orally bioavailable small-molecule inhibitor of JAK1 and JAK2 markedly selective over JAK3. Treatment of myeloma cells with INCB16562 potently inhibited interleukin-6 (IL-6)-induced phosphorylation of STAT3. INCB16562 abrogated the protective effects of recombinant cytokines or bone marrow stromal cells and sensitized myeloma cells to cell death by exposure to dexamethasone, melphalan, or bortezomib. Oral administration of INCB16562 antagonized the growth of ... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN7421 |
Beta-Dimorphecolic acid (9(S)-HODE)
|
Others | Others |
Dexamethasone exhibits anti-inflammatory activity. |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPJ-00584 |
Bc1-w Protein, Human, Recombinant (His)
Apoptosis Regulator Bcl-W,KIAA0271,Bcl-2-Like Protein 2,Bcl2... |
Human | E. coli |
Bcl-2-like protein 2 (BCL2L2) belongs to the Bcl-2 family. BCL2L2 is highly expressed in thebrain, spinal cord, testis, pancreas, heart, spleen, and mammary glands. BCL2L2 is a peripheral membrane protein containing three motifs, BH1, BH2 and BH4. The BH4 motif appears to be involved in the anti-apoptotic function. The BH1 and BH2 motifs form a hydrophobic groove which acts as a docking site for the BH3 domain of some pro-apoptotic proteins. BCL2L2 promotes cell survival and blocks dexamethasone... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TMIH-0186 |
Dexamethasone-d5
|
||
Dexamethasone-d5 是 Dexamethasone 的氘代化合物。 | |||
TMIJ-0162 |
Dexamethasone-d4
|
||
Dexamethasone-d4 是 Dexamethasone 的氘代化合物。Dexamethasone 的 CAS 号为 50-02-2。Dexamethasone是一种糖皮质激素受体激动剂和一种 IL 受体调节剂。在脂多糖诱导的巨噬细胞炎症反应中,它抑制含有炎性 microRNA-155 的外泌体的产生。 |